Article Text

Download PDFPDF
Metabolic syndrome common in people with psychotic disorders, particularly in users of high potency antipsychotics

Statistics from


  • Source of funding: Grants from Stanley Medical Research Institute, Yrjo Jahnsson Foundation, and the Academy of Finland.

  • ▸ Additional notes and a reference list are published online only at


  • Competing interests: SS has received honoraria for lectures from Eli Lilly, Astra Zeneca, Bristol Myers Squibb and Janssen, and educational grants from Eli Lilly and Astra Zeneca.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.